Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-33495226

ABSTRACT

Artemisinin (ART)-based antimalarial drugs are believed to exert lethal effects on malarial parasites by alkylating a variety of intracellular molecular targets. Recent work with live parasites has shown that one of the alkylated targets is free heme within the parasite digestive vacuole, which is liberated upon hemoglobin catabolism by the intraerythrocytic parasite, and that reduced levels of heme alkylation occur in artemisinin-resistant parasites. One implication of heme alkylation is that these drugs may inhibit parasite detoxification of free heme via inhibition of heme-to-hemozoin crystallization; however, previous reports that have investigated this hypothesis present conflicting data. By controlling reducing conditions and, hence, the availability of ferrous versus ferric forms of free heme, we modify a previously reported hemozoin inhibition assay to quantify the ability of ART-based drugs to target the heme detoxification pathway under reduced versus oxidizing conditions. Contrary to some previous reports, we find that artemisinins are potent inhibitors of hemozoin crystallization, with effective half-maximal concentrations approximately an order of magnitude lower than those for most quinoline-based antimalarial drugs. We also examine hemozoin and in vitro parasite growth inhibition for drug pairs found in the most commonly used ART-based combination therapies (ACTs). All ACTs examined inhibit hemozoin crystallization in an additive fashion, and all but one inhibit parasite growth in an additive fashion.


Subject(s)
Antimalarials , Artemisinins , Hemeproteins , Pharmaceutical Preparations , Antimalarials/pharmacology , Artemisinins/pharmacology , Heme , Plasmodium falciparum
2.
Chem Sci ; 10(23): 5976-5982, 2019 Jun 21.
Article in English | MEDLINE | ID: mdl-31360404

ABSTRACT

Access to diverse, relatively high molecular weight soluble linear polymers without pendant solubilizing chains is the key to solution state synthesis of structurally diverse nanoribbons of conjugated materials. However, realizing soluble 1D-π-conjugated polymers without pendant solubilizing chains is a daunting task. Herein, inspired from the polypeptide ß-strand architecture, we have designed and developed novel bifacial π-conjugated polymers (M n: ca. 24 kDa) that are soluble (ca. 70 to >250 mM) despite the absence of pendant solubilizing chains. The impact of varying the bifacial monomer height on polymer solubility, optical properties, and interactions with small molecules is reported.

3.
J Pept Sci ; 24(3)2018 Mar.
Article in English | MEDLINE | ID: mdl-29430772

ABSTRACT

Diastereoselective addition of nitromethane to Boc-D-Phe-H in the presence of sodium hydride in diethyl ether/hexane containing 15-crown-5 and subsequent N,O-protection with 2,2-dimethoxypropane gave trans-oxazolidine in a diastereomeric ratio of >16:1. The oxazolidine was easily separated by column chromatography, which after Nef reaction was coupled to H-Leu-OtBu. The 8-step synthesis afforded (-)-bestatin in an overall yield of 24.7% after deprotection and ion exchange.


Subject(s)
Leucine/analogs & derivatives , Chromatography, High Pressure Liquid , Leucine/chemical synthesis , Leucine/chemistry , Molecular Structure , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...